In its submission to the consultation on the Regulation Impact Statement for country of origin labelling, ASMI says it advocated for voluntary country of origin labelling for therapeutic goods. "ASMI supports sponsors who wish to include a country of origin statement on therapeutic goods labels," says Steve Scarff, ASMI Regulatory and Scientific Affairs Director. "However,
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.